Novome Biotechnologies Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 35
Employees
  • Latest Deal Type
  • Series A1
  • Latest Deal Amount
  • $33M
Latest Deal Amount
  • Investors
  • 6

Novome Biotechnologies General Information

Description

Developer of a drug discovery platform intended to develop cell-based therapeutics. The company's platform utilizes engineered gut bacteria for treating diseases, enabling doctors to help patients to achieve long-term health.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Biotechnology
Primary Office
  • 279 East Grand Avenue
  • Suite 420
  • South San Francisco, CA 94080
  • United States

Novome Biotechnologies Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Novome Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC (Series A1) 06-Jan-2020 $33M 000.00 0000 Completed Generating Revenue
5. Grant 27-Aug-2019 00000 00000 Completed Generating Revenue
4. Grant 15-Aug-2018 00000 00000 Completed Generating Revenue
3. Seed Round 09-Mar-2018 00.00 00000 Completed Generating Revenue
2. Angel (individual) 09-Jan-2017 $536K $536K Completed Generating Revenue
1. Grant 15-Dec-2016 $225K Completed Generating Revenue
To view Novome Biotechnologies’s complete valuation and funding history, request access »

Novome Biotechnologies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1 00,000,000 00.000000 00.00 00.00 00 00.00 000
Series A-3 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-2 2,119,798 $0.001000 $1.65 $1.65 1x $1.65 10.91%
To view Novome Biotechnologies’s complete cap table history, request access »

Novome Biotechnologies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a drug discovery platform intended to develop cell-based therapeutics. The company's platform utilizes engi
Drug Discovery
South San Francisco, CA
35 As of 2021
000.00
000 0000-00-00
00000000000 000.00

0000000

xercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repreh
0000 000000000
Cambridge, MA
000 As of 0000
00000
00000000000 00000

00000 00

esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in
0000000000000
Cambridge, MA
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Novome Biotechnologies Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vedanta Biosciences Venture Capital-Backed Cambridge, MA 000 00000 00000000000 00000
00000 000000000000 Formerly VC-backed Cambridge, MA 000 00000 000000000 00000
00000 00000000000 Formerly VC-backed Cambridge, MA 00 00000 000000000 00000
00000000 Formerly VC-backed Cambridge, MA 00 00000 000000 - 000 00000
0000000 Venture Capital-Backed Stockholm, Sweden 00 00000 00000000000 00000
You’re viewing 5 of 7 competitors. Get the full list »

Novome Biotechnologies Executive Team (8)

Name Title Board Seat Contact Info
William DeLoache Ph.D Co-Founder, Chief Scientific Officer & Board Member
Shu Kurosaki Controller
Justin Sonnenburg Ph.D Co-Founder & Scientific Advisory Board Member
Liz Shepherd Ph.D Co-Founder
Zachary Russ Ph.D Co-Founder
You’re viewing 5 of 8 executive team members. Get the full list »

Novome Biotechnologies Board Members (10)

Name Representing Role Since
Andrew Schwab 5AM Ventures Board Member 000 0000
Daniel Janney Alta Partners Board Member 000 0000
David Cook Ph.D Novome Biotechnologies Board Member 000 0000
Kiersten Stead Ph.D DCVC Bio Board Member 000 0000
Mira Chaurushiya Ph.D 5AM Ventures Board Observer 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Novome Biotechnologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novome Biotechnologies Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
Alta Partners Venture Capital Minority 000 0000 000000 0
DCVC Bio Venture Capital Minority 000 0000 000000 0
Mayo Clinic VC-Backed Company Minority 000 0000 000000 0
5AM Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »